Vanguard Group Inc - Mar 31, 2025 SCHEDULE 13G Report for Keros Therapeutics Inc Common Stock (KROS)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Keros Therapeutics Inc Common Stock
Symbol: KROS
Shares outstanding: 40.6M shares
Disclosed Ownership: 2.57M shares
Ownership: 6.32%
Form type: SCHEDULE 13G
Date filed: 4/30/2025, 11:23 AM
Date of event: Mar 31, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	6.32%	2.57M	0	31.1K	Ashley Grim	Head of Global Fund Administration